Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Drug Therapy × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Gynecologic 1 Breast 1

Conditions

Ovarian Neoplasms 39 Fallopian Tube Neoplasms 17 Uterine Cervical Neoplasms 16 Carcinoma, Ovarian Epithelial 12 Endometrial Neoplasms 7 Neoplasms 6 Lung Neoplasms 4 Stomach Neoplasms 3 Recurrence 3 Peritoneal Neoplasms 3 Neoplasm Metastasis 3 Gestational Trophoblastic Disease 3 Breast Neoplasms 3 Vulvar Neoplasms 2 Pancreatic Neoplasms 2 Melanoma 2 Hydatidiform Mole 2 Head and Neck Neoplasms 2 Gynecologic Cancer 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma 2 Virus Diseases 1 Vaccinia 1 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Sarcoma 1 Poxviridae Infections 1

Interventions

Cisplatin 4 Radiotherapy 2 Cytoreduction Surgical Procedures 2 Conization 2 Brachytherapy 2 sodium thiosulfate 1 Radiation 1 Hyperthermic Intraperitoneal Chemotherapy 1 Drug Therapy 1 Diathermy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03332069 2017-11-07

mEHT

University of Witwatersrand, South Africa

Phase 3 Unknown

Hyperthermia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡